-
HDAC Inhibitors Repress NUT Function in Carcinoma
2026-09-12
Shiota and colleagues developed a dCas9-based reporter screen that unexpectedly identified chemically diverse HDAC inhibitors as repressors of oncogenic NUT transcriptional activity. The study connects HDAC inhibition with loss of BRD4-NUT megadomain function, tumor-cell differentiation, and improved suppression of NUT carcinoma in combination with bromodomain inhibition.
-
JNJ-26854165 (Serdemetan) Workflow Guide
2026-09-11
Build more informative Serdemetan experiments by separating growth arrest from true cell killing, while preserving the compound’s p53-centered mechanism. This practical guide covers dose design, orthogonal readouts, radiosensitization studies, formulation, and troubleshooting for cancer research.
-
Entecavir (BMS200475) for HBV Research
2026-09-11
Entecavir (BMS200475) provides a practical platform for measuring HBV DNA suppression, comparing wild-type and lamivudine-resistant strains, and linking cell-based potency to clinically meaningful outcomes. This workflow-centered guide covers assay setup, protocol parameters, resistance-focused experiments, and troubleshooting for translational HBV research.
-
Exosomal TIE2 Transfer Drives Macrophage Angiogenesis
2026-09-10
The reference study shows that exosomes from TIE2-high cervical cancer cells transfer TIE2 protein directly to macrophages, generating a proangiogenic TIE2-expressing macrophage population. Its tissue, cell, and animal data connect tumor-derived extracellular vesicles with macrophage programming and suggest practical protein-preservation considerations for validating this pathway.
-
H-89 as a Causal Probe of Wnt–PKA Metabolism
2026-09-10
H-89 is a cAMP-dependent protein kinase inhibitor for dissecting how Wnt signaling connects PKA activity with O-GlcNAcylation, glycolysis, and osteoblast function. This guide presents a time-resolved assay strategy that separates early pathway events from later metabolic and phenotypic consequences.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-09-09
TBST is a ready-to-use buffered detergent solution for reducing nonspecific background during antibody-based workflows, including Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. It should be used within validated immunoassay protocols and not assumed to be suitable for cell culture, injection, or detergent-sensitive assay chemistries.
-
Wnt-C59: Precision PORCN Inhibition Workflows
2026-09-09
Wnt-C59 enables mechanism-first studies of ligand-dependent Wnt signaling, from TCF reporter assays and cholangiocarcinoma phenotyping to exploratory exosome biology. This guide combines practical dosing, assay controls, troubleshooting, and a carefully bounded connection to lithium-engineered BMSC exosomes.
-
Cefotaxime Workflows for Resistance Research
2026-09-08
Build reproducible Cefotaxime assays that connect beta-lactam phenotyping with plasmid transfer, gene localization, and bacterial infection model design. This practical guide emphasizes fresh-solution handling, controls, comparative testing, and troubleshooting for antimicrobial resistance research.
-
Kidney Progenitor Assembloids for Disease Modeling
2026-09-08
Huang et al. developed spatially organized mouse and human kidney progenitor assembloids that reproduce key self-assembly relationships between nephron and collecting-system progenitors. The models improve tissue complexity, maturation, function, and autosomal dominant polycystic kidney disease modeling, while offering a more physiologically informative platform than conventional kidney organoids.
-
Sunitinib Beyond Angiogenesis: A Translational Playbook
2026-09-07
Sunitinib is more than an anti-angiogenic benchmark: it is a mechanistically rich platform for studying RTK signaling, apoptosis, cell-cycle control, and resistance in renal cell carcinoma. This translational guide connects multi-target inhibition with recent evidence that Syringin may enhance Sunitinib sensitivity through EGFR/PI3K/Akt signaling.
-
Faropenem Sodium: Transport-Aware Assay Design
2026-09-05
Faropenem sodium is a penem antibiotic whose antibacterial profile can be studied more rigorously when transporter biology, formulation, and microbiological endpoints are interpreted together. This guide translates NPT1 transport evidence into practical assay decisions without confusing renal handling with direct evidence of clinical efficacy.
-
Rotigotine Antidepressant Effects in Depression Models
2026-09-05
This 2006 study tested rotigotine across behavioral models of anxiety and depression, showing improved forced-swim mobility, learned-helplessness escape behavior, and bulbectomy-associated hyperactivity at selected doses. Its central contribution is the distinction between potentially antidepressant-range effects at lower doses and locomotor stimulation that can confound interpretation at higher exposure.
-
Atrial Natriuretic Peptide: Research Workflows
2026-09-04
Build more informative blood pressure, renal sodium-handling, and adipose-metabolism experiments with a controlled rat ANP workflow. This guide combines product handling, assay design, translational interpretation, and troubleshooting while clearly separating ANP applications from evidence generated with adiponectin.
-
NSP15 Inhibitor Screening: Thymopentin and Oleuropein
2026-09-04
This 2021 study used structure-based virtual screening and molecular dynamics to prioritize natural products against the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein formed the most favorable and stable computational complexes, but biochemical, cellular, and clinical validation remain necessary before they can be considered antiviral inhibitors.
-
Cy3 TSA Fluorescence System Kit for Olfactory Receptors
2026-09-03
The Cy3 TSA Fluorescence System Kit brings localized tyramide signal amplification to IHC, ICC, and ISH workflows where conventional fluorescence may miss scarce receptor protein or RNA. Applied alongside the structural insights from Olfr110 research, it supports sensitive spatial validation without confusing localization evidence with proof of ligand binding or receptor activation.